These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17723158

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 8. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G, Dahlöf CG, Mathew N, Nappi G.
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [Abstract] [Full Text] [Related]

  • 9. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC, Ashcroft DM.
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [Abstract] [Full Text] [Related]

  • 12. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.
    Headache; 2004 Feb; 44(7):661-8. PubMed ID: 15209687
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J.
    Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG.
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.